Could fructose be fueling ovarian cancer's spread?

Could fructose be fueling ovarian cancer's spread?

Researchers at The Wistar Institute have uncovered a surprising new player in ovarian cancer metastasis: fructose. Published in Nature Aging, the study found that cancer cells surviving platinum-based chemotherapy don't just go quiet — they actively release fructose into their surroundings, which acts as a chemical signal that encourages neighboring tumor cells to break free and spread. This is one of the first studies to show, in a preclinical model, that it's the molecules these surviving cells release — not the cells themselves — that drive metastasis.

The mechanism works through cholesterol. Fructose suppresses cholesterol production in nearby cancer cells, weakening the membrane connections that normally hold cells together. With that "biological glue" loosened, cancer cells can detach and migrate more easily. Alarmingly, statins — taken by ~39 million Americans — showed a similar cholesterol-suppressing effect on cancer cell connections, raising questions about their interaction with chemotherapy in ovarian cancer patients, who are often postmenopausal and already on statins.

Key Takeaways:

• Chemo-surviving cancer cells release fructose that promotes metastasis — even without actively dividing
• High dietary fructose intake (accounting for 8–20% of daily calories for some Americans) may independently promote cancer-spread signals
• Statins alone could weaken cancer cell-to-cell connections in preclinical models
• Researchers suspect similar mechanisms may apply to pancreatic, colon, and liver cancers

Why it matters: Metastasis drives approximately 90% of ovarian cancer deaths, and most patients see their cancer return after chemotherapy. Identifying fructose as a metastatic signal could open doors to nutritional strategies and medication adjustments that complement cancer treatment — though human trials are still needed before any clinical recommendations can be made.